ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion?

被引：0
|
作者：
Christopher W. Mangieri
Cristian D. Valenzuela
Ian B. Solsky
Richard A. Erali
Konstantinos I. Votanopoulos
Perry Shen
Edward A. Levine
机构：
[1] Wake Forest University School of Medicine,Wake Forest Baptist Health Medical Center, Division of Surgical Oncology
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2496 / 2496
相关论文
共 50 条
  • [1] ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2496 - 2496
  • [2] Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2486 - 2493
  • [3] Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Christopher W. Mangieri
    Cristian D. Valenzuela
    Ian B. Solsky
    Richard A. Erali
    Konstantinos I. Votanopoulos
    Perry Shen
    Edward A. Levine
    Annals of Surgical Oncology, 2023, 30 : 2486 - 2493
  • [4] Exposure to Neoadjuvant Oxaliplatin Containing Chemotherapy, Does It Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
    Mangieri, Christopher W.
    Valenzuela, Cristian D.
    Solsky, Ian B.
    Erali, Richard A.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 519 - 519
  • [5] ASO Author Reflections: Neoadjuvant Oxaliplatin Therapy for Peritoneal Carcinomatosis, Any Impact on Subsequent Hyperthermic Intraperitoneal Chemotherapy Perfusion?
    Christopher W. Mangieri
    Edward A. Levine
    Annals of Surgical Oncology, 2023, 30 : 2494 - 2495
  • [6] ASO Author Reflections: Neoadjuvant Oxaliplatin Therapy for Peritoneal Carcinomatosis, Any Impact on Subsequent Hyperthermic Intraperitoneal Chemotherapy Perfusion?
    Mangieri, Christopher W.
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2494 - 2495
  • [7] ASO Visual Abstract: Triphasic Learning Curve of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Ciftci, Yusuf
    Radomski, Shannon N.
    Johnson, Blake A.
    Johnston, Fabian M.
    Greer, Jonathan B.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 254 - 254
  • [8] ASO Visual Abstract: Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix
    Felipe Lopez-Ramirez
    Vadim Gushchin
    Michelle Sittig
    Mary Caitlin King
    Ekaterina Baron
    Andrei Nikiforchin
    Carol Nieroda
    Armando Sardi
    Annals of Surgical Oncology, 2022, 29 : 3404 - 3404
  • [9] ASO Visual Abstract: Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo
    Eun Jung Park
    Junhyun Ahn
    Sharif Md Abuzar
    Kyung Su Park
    Sung-Joo Hwang
    Seung Hyuk Baik
    Annals of Surgical Oncology, 2022, 29 : 8595 - 8596
  • [10] Hyperthermic intraperitoneal perfusion chemotherapy—views on the observed variability in oxaliplatin pharmacokinetics
    Nuggehally R. Srinivas
    European Journal of Clinical Pharmacology, 2009, 65 : 321 - 322
12345